6056 Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer (mCRC) patients (pts): is efficacy mantained?

✍ Scribed by Grande, R.; Cianci, G.; Grassi, G.; Sperduti, I.; Narducci, F.; Gelibter, A.; Nuzzo, C.; Mentuccia, L.; Giampaolo, M.A.; Gamucci, T.

• Book ID: 121915554
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 48 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71151-6